Women love their hair. They devote time, energy and money to helping it feel and look its best. It’s even a means of self-expression, sometimes more so than a woman’s clothing.
BIOTA Botanicals set out to take the pulse of American women regarding how they really feel about their hair – especially as they (and it) ages.
According to the national consumer survey, most women 30+ have already noticed and worry about the density of their hair as they age. In fact, more women are concerned about thinning-damaged hair than they are about going grey (58% vs. 51%).+ Many say that the condition is embarrassing and a clear-cut sign of getting older, and most agree that it’s an unpreventable fate.
Says Kelli Calabrese, renowned health, beauty and lifestyle expert, “The problem with thinning-damaged hair is not always what’s visible,” she says. “It’s how it rocks a woman’s self-esteem. For women, who put so much emotional value on their hair, it can be absolutely devastating for their self image and emotional well-being.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7598951-biota-fall-beauty-tips/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For North America
Dr. Danielle Marcoux from Canada
Camp Liberté – Summer camp for children with skin disorders
This one-week summer camp run by volunteer dermatologists and nurses enrolled children aged 7 to 12 with moderate-to-severe skin disorders, as well as their families, to bring them together for support, social interaction and to increase their confidence. All the activities aim to increase patients’ confidence and self-esteem, improve social skills, reduce stigma about their condition and improve adherence to treatment.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Asia-Pacific
Dr. Jeong Chan-woo from South Korea
Sharing skin love - Skin Health Promotion for Orphanage and for low-income children/youth
This initiative was established to help children from low-income families, without parents or those living away from their parents, to receive education on how to prevent skin diseases. They also have access to high quality treatment if they are suffering from a dermatological condition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Africa and Arab States
Prof. Khalid Mohammed AlGhamdi from Saudi Arabia
Charity Society known as Faal to empower and support vitiligo patients in Saudi Arabia
Vitiligo is a long-term skin condition that causes pale, white patches on the skin due to a lack of melanin. This project aimed to increase awareness via TV broadcasts, schools visits and to provide psychological and social support to patients with vitiligo through training courses and different education programs.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
To find out more on the different types of car insurance in NSW visit http://www.nrma.com.au
At NRMA Insurance, we’re here to give you all the information you need to choose the best policy for you.
That means understanding the difference between agreed value and market value when you take out our Comprehensive Car Insurance.
One is not necessarily better than the other. It’s about which one is right for you.
Say your car is a total loss and you have chosen agreed value on your comprehensive car insurance policy.
Agreed value is a fixed value, that we agree to insure your car for upfront, which includes modifications, options and accessories. This gives you the confidence of knowing how much we’ll pay you if your car is a total loss, less any fees and charges. People often prefer an agreed value if they have finance owing on their car.
Market Value on the other hand is the value of your car as determined when an incident happens. This is influenced by such factors as local market prices, as well as the age and condition, of your car. It can be a cheaper option, as the amount you’ll receive is uncertain.
We hope this has been informative and you’re now ready to go. Remember that, whether you’re insuring a new car, the weekend wagon or a family hand-me-down, the decision to insure your vehicle for either its Agreed Value or Market Value is entirely up to you with our Comprehensive Car Insurance.
If you would like to know more, call us on 132 132.
NRMA Insurance. It’s insurance, just NRMADE Better.
Top of the mountain, five percent battery remaining, no outlet in sight. Decision time: go back or keep going? Adventurers can now go further in almost any condition with FRĒ Power from LifeProof, doubling the battery life of iPhone 6.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7525051-lifeproof-announces-fre-power/
The Pinch Arete on the Wellington Block at Harrisons Rocks,Birchden Wood,Groombridge.The route was very damp on this day but on a warmer day is excellent.
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
The latest lash breakthrough is here. From Rimmel, you can get the Moroccan Argan oil your hair loves in a Rimmel mascara with new Wonder’lash Mascara with Argan Oil. Condition lashes and break through clumps for full, smooth volume. The unique brush’s super-soft bristles hug and coat each lash, perfectly separating them from root to tip. Even small corner lashes are dramatically transformed for an effortlessly eye-catching look. Lashes are left smoother, sleeker, and more defined than ever.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7428651-rimmel-london-wonder-lash/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the initiation of production of The PBA Film Project (working title), the first-ever documentary to provide an intimate look at real people living with a little-known neurologic condition called PseudoBulbar Affect (PBA). The award-winning filmmaker team of The PBA Film Project includes co-directors Doug Blush and Lisa Klein (Of Two Minds) and producer Julian Cautherley (The Crash Reel).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7266955-avanir-pharmaceuticals-pseudobulbar-affect-pba-documentary/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
